Granules India plant passes FDA inspection; Aurobindo building warehouse in New Jersey;

> Granules India reported that the FDA inspected its plant in Gagillapur near Hyderabad in response to an ANDA and had no observations. Report

> Indian drugmaker Aurobindo will build a new warehouse and hire 300 workers in East Windsor, NJ. Report

> Porton Fine Chemicals of Chongqing, a Chinese contract manufacturer of intermediates, will acquire competitor Jiangxi Dongbang Pharmaceutical in a $41.5 million deal. Report

Suggested Articles

The eight-year deal will initially cover lupus drug Benlysta and could expand to other GSK specialty-care products in the future.

With a new £131 million contribution from the U.K. government, VMIC aims to both speed up and expand on its prior ambitions.

Pricing controversies shouldn't overshadow Phlow's promise to provide low-cost drugs to address COVID-19, says the CEO of partner Civica Rx.